Rocket Pharmaceuticals Inc (STU:9IP1)
€ 15.785 -0.22 (-1.37%) Market Cap: 1.43 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 4.65 GF Score: 30/100

Rocket Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / NTS GMT
Release Date Price: €15.4 (-0.65%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Thank you, everyone. My name is Gena Wang. I'm SMid-Cap biotech analyst at Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, the investors, companies and especially our event team and corporate access team, who made this virtual health care conference possible.

With that, I would like to introduce our next speaker, Gaurav Shah, President and CEO from Rocket. Gaurav, I will hand over to you.

Gaurav Shah
Rocket Pharmaceuticals, Inc. - CEO, President & Director

Hi, Gena. Thank you, and thank you for continuing to host this webcast despite the travel restrictions. And I also hope everyone stays healthy and safe in the days to come. So I will spend a few minutes talking through an overview of Rocket. And then, I think, Gena, you and I can go back and forth on Q&A.

So this is the decade of gene therapy. We're very excited about the prospect of being a part of that evolving gene therapy story for curative medicines for really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot